During the COVID-19 pandemic, therapeutic development took a backseat to vaccines – a potentially disastrous gamble had vaccines not been found. In future pandemics, therapeutics and vaccines should be treated equally – particularly as COVID-19 treatment options remain expensive and mostly only available in high-income countries, speakers told at a webinar this week hosted by […] Continue reading ->
CAPE TOWN – Moderna tried to extract a huge price for its COVID-19 vaccine from the South African government at the height of the pandemic, according to the local NGO, Health Justice Initiative (HJI), in revelations made public this week. The US-based pharma company wanted to charge $42 per vaccine in mid-2021 when vaccines were […] Continue reading ->
WHO has expanded its list of trusted national regulatory authorities from three to 36 agencies – including the United States Food and Drug Adminstration (FDA), the European Medicines Agency (EMA) as well as the European Medicines Regulatory Network (EMRN), composed of the European Commission, and thirty national regulatory agencies. The WHO Listed Authorities (WLAs) are […] Continue reading ->
Researchers have developed a new all-in-one vaccine aimed at priming the body to respond to a range of different strains of coronaviruses, including the ones not yet known. The researchers from Cambridge, MIT and CalTech published their findings recently in Nature Nanotechnology. Their vaccine was successfully tested on mice and will likely enter human clinical trials […] Continue reading ->
With Gaza’s Rafah crossing into Egypt closed by an advancing Israeli incursion, and Israel’s Kerem Shalom crossing shut since last Sunday’s Hamas missile attack, Gaza hospitals have only about three days left of fuel and medical supplies, said WHO Director General Dr Tedros Adhanom Ghebreyesus Wednesday.     The global health agency is making contingency plans for […] Continue reading ->
The Novo Nordisk Foundation, Bill & Melinda Gates Foundation, and Wellcome Trust have announced a new partnership, committing $300 million over three years to stimulate innovative research in developing countries into three of the world’s most critical global health challenges and their interlinkages – including climate change, infectious diseases and antimicrobial resistance (AMR). An additional […] Continue reading ->